Q: who is right the long or shorts on valeant
is it a buy under todays price drop
is it a buy under todays price drop
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I am still holding PHM . Is there any hope in the near future for this stock or should I sell it?
Margita
Margita
Q: I have had a very steep roller coaster ride (mostly down) with NHC and am currently out of it. Having just watched the interview on BNN with the CEO Chris Llyod and the announcement of the $300 M lawsuit, I am considering taking a position in NHC yet again. Do you see any merit in the lawsuit; and if you watched the interview or read reports of the NHC response: would any of this provide you with sufficient reason to buy the stock. Thanks.
Q: I am a retired, mostly conservative dividend-income investor with a pension, CPP and annuities. My asset mix is 65% equities and 35% fixed income. My holdings include AD, ALA, AQN, BNS, BCE, CGX, CPG, PBH, RY, SLF, WCP, WEF, WSP, ZLB, XIT and Sentry Cdn Income, Sentry REIT, TD Health, RBC Cdn Equity Income.
Within my equity portfolio, my tech exposure is 8% with 3/4 of that being XIT. Seasonality is in its favor right now.
Within my equity portfolio, my healthcare exposure is 4%, with 3/4 of that being TD Health. Bad current news environment and bad seasonality, but beaten down.
I am interested in topping up either XIT or TDB976. Which one is more conservative, could use the topping up and has the most upside?
Thanks,
Steve
Within my equity portfolio, my tech exposure is 8% with 3/4 of that being XIT. Seasonality is in its favor right now.
Within my equity portfolio, my healthcare exposure is 4%, with 3/4 of that being TD Health. Bad current news environment and bad seasonality, but beaten down.
I am interested in topping up either XIT or TDB976. Which one is more conservative, could use the topping up and has the most upside?
Thanks,
Steve
Q: Would appreciate your take on earnings announced today. Would you continue to hold for projected recovery?
Thanks
Thanks
Q: I would like to increase my Health Care section - right now I only hold GUD. Looking for help in finding something fairly solid with a moderate growth record and reasonable divi and not subject to being affected by stuff like the recent Valeant thingy. Thx guys.
Q: Hi Peter, At first I want to say that I did not listen to your advice on portfolio diversification and allocated 25% of my portfolio to Concordia by averaging down when it was going down. My average cost is CAD$44. I am now down 18% as CXR is down 8% today. I am very uncomfortable with this, I have other 46 stocks having 75% of my portfolio(most of them from your growth and balance portfolio) and then I have CXR which is 25% of my portfolio. Question to you is this: 1. Do you know why it is down today(could not find any news or downgrade)? 2. Is there any catalyst coming(except quarterly result on 10th November) 3. I see its volume is below average last couple of days, do you think professional money manager will buy this name again? Or how and why the price going to go up? 4. How do you want me unwind the position, I don't want to sell now as I am 18% down, should I sell when the price comes back up to my average cost? 5. I read the report by Ryan and all other analyst reports on CXR and it convinced me that there is significant upside to this name, so should I hold it? This is in my taxable margin account.
Q: Do you think these small cap health care can bounce back in a 3-6 month period or do you think there is a possibility they could drift sideways and down for a longer period of time,is part of their problems the headwinds of valiant and Concordia thank you.They make up about 15% of my portfolio.
Q: I appreciate your response to this question
Nobles health in Canada is NHC-T and in US HLTH-N
Is it better to buy in US account or CAN account?-The pro and con.Thank you.ebrahim
Nobles health in Canada is NHC-T and in US HLTH-N
Is it better to buy in US account or CAN account?-The pro and con.Thank you.ebrahim
Q: Hello Peter & 5i team,
In my Health Care exposure (6% of portfolio), I hold CRH,CXR,GUD,PLI that I plan to keep. I also own PHM and RX. RX is profitable and has a whopping ROE of 48% and its forward PE of 20 is amply covered by the ROE with a ratio of 2.4 whereas PHM is not profitable (ROE of -20%); I don't have any info on their debt level and presume RX's is higher.
Given this cursory comparison + your insight, which would you keep if you had to chose one?
Thanks,
Antoine
In my Health Care exposure (6% of portfolio), I hold CRH,CXR,GUD,PLI that I plan to keep. I also own PHM and RX. RX is profitable and has a whopping ROE of 48% and its forward PE of 20 is amply covered by the ROE with a ratio of 2.4 whereas PHM is not profitable (ROE of -20%); I don't have any info on their debt level and presume RX's is higher.
Given this cursory comparison + your insight, which would you keep if you had to chose one?
Thanks,
Antoine
Q: Crh showing more weakness today would you consider this a buying opportunity I have 5% weighting of this in my portfolio and am down 25 %.What kind of timeframe do you think this might take to recover
Q: This stock is getting pounded again today. Any reason for this other than the sector and the "shorts" running rampant? I didn't think the financials were really out of line.
thx for any and all info
thx for any and all info
Q: Good morning. My best wishes to all, and I hope everyone is well. I am puzzled as Concordia continues to be punished while Valeant is having a nice pop. I purchased a small position in CXR based on the thinking that the baby had been thrown out with the bathwater. It seemed to me that CXR was condemned as guilty by association. Are there any other factors at work here? Would you consider adding to the position once the rout ends?
Thank you.
Thank you.
Q: Hello Team,
Could you give me your opinion on this company and how would you rate it compared to csh.
Thank You,
Barry
Could you give me your opinion on this company and how would you rate it compared to csh.
Thank You,
Barry
Q: I just discovered that this stock has been delisted from the Nasdaq. Can I sell my shares through the TSE? What are your thoughts on the stock/
Q: I know this isn't a chat forum but I am intrigued by Saeed's question and wished to comment. Perhaps food for thought for some other members. I took a close look at Valeant also, because some of the selling was motivated by fear, and this can represent an opportunity. I chose to pass because:
1) I don't really understand how they are making the profits they report. They buy established companies with valuable products. OK. But what are they adding that allows them to earn so much more than the original owner? It is hard for me to believe that they can continue to grow this fast for very long. Anyhow, if I don't understand the business, I don't buy the shares.
2) VRX response to Citron, to me, was all bluster and obfuscation. VRX never came out and said in plain language that all their sales were absolutely legitimate. Instead they seemed to emphasize that their accounting was technically legal. And, by the way, whenever any organization delays giving answers but instead hires a team to "investigate" themselves....that is a sure sign they have been caught doing something wrong. It is a tactic to delay and hide the truth.
I hope for Saeed and others that VRX wrongdoing is only minor and that the core of the business is legit. Would be good for us all if it bounced back. I'll be on the sidelines though.
1) I don't really understand how they are making the profits they report. They buy established companies with valuable products. OK. But what are they adding that allows them to earn so much more than the original owner? It is hard for me to believe that they can continue to grow this fast for very long. Anyhow, if I don't understand the business, I don't buy the shares.
2) VRX response to Citron, to me, was all bluster and obfuscation. VRX never came out and said in plain language that all their sales were absolutely legitimate. Instead they seemed to emphasize that their accounting was technically legal. And, by the way, whenever any organization delays giving answers but instead hires a team to "investigate" themselves....that is a sure sign they have been caught doing something wrong. It is a tactic to delay and hide the truth.
I hope for Saeed and others that VRX wrongdoing is only minor and that the core of the business is legit. Would be good for us all if it bounced back. I'll be on the sidelines though.
Q: Hello team,
On Monday last week, I purchased a 10% position in Valeant. This was after seeing the videos on BNN on both side and also asking you a question about my decision to do this. I reasoned that I am a long-term investor and I would not touch this money for at least another 10 years. This has not changed. What has made me question my original decision however is the promise of new report that is even worse, further reveals Valeant’s accounting practices, and shall “nail” the company following their presentation last Monday. I didn’t think philidor story could carry that much weight in the end and that is why I bought in. Now, I think where this whole story is going to stop with a masterfully planned report releases to do maximum damage. Would that point be “beyond point of repair” for the company?
I know everything is possible and I know you cautioned me against too much weight here. I made the mistake and I learned my lesson. My question here is how much I have to pay for the lesson. I know that the additional loss on Friday was a response to the news for this Monday release and the damage is already in the stock again. What I am asking here is: should I look away and ignore all of this noise or should I at least try to lower my weighting and reduce my overall losses. I will be still holding the company if it happens to be around 10 years from now.
I think time is the only thing I have on my side as a retail investor. Andrew Left and other short sellers have made their money. Bill Ackman will make money by averaging down. And perhaps, I won’t lose money if I sit still and don’t react at all.
What do you think?
Having you guys at 5i cannot be appreciated enough during such times. Thank you!
On Monday last week, I purchased a 10% position in Valeant. This was after seeing the videos on BNN on both side and also asking you a question about my decision to do this. I reasoned that I am a long-term investor and I would not touch this money for at least another 10 years. This has not changed. What has made me question my original decision however is the promise of new report that is even worse, further reveals Valeant’s accounting practices, and shall “nail” the company following their presentation last Monday. I didn’t think philidor story could carry that much weight in the end and that is why I bought in. Now, I think where this whole story is going to stop with a masterfully planned report releases to do maximum damage. Would that point be “beyond point of repair” for the company?
I know everything is possible and I know you cautioned me against too much weight here. I made the mistake and I learned my lesson. My question here is how much I have to pay for the lesson. I know that the additional loss on Friday was a response to the news for this Monday release and the damage is already in the stock again. What I am asking here is: should I look away and ignore all of this noise or should I at least try to lower my weighting and reduce my overall losses. I will be still holding the company if it happens to be around 10 years from now.
I think time is the only thing I have on my side as a retail investor. Andrew Left and other short sellers have made their money. Bill Ackman will make money by averaging down. And perhaps, I won’t lose money if I sit still and don’t react at all.
What do you think?
Having you guys at 5i cannot be appreciated enough during such times. Thank you!
Q: I wonder if you are able to clarify Knight's business model with respect to the degree it aquires companies and then agressivley jacks up the price of existing drugs. This unseemly practice appears to be one of the big complaints about Valent and the possibility that legislators will go after drug companies and bring in regulations. I do not see that explicitly referred to in your 5i report but would like your opinion on this matter. I want to make money like everyone else, and I have read Ryan's blog on Valeant, but to the extent that the allegations in this regard are true, it seems a risky business model (and probably unethical) to me and the public at large. Thanks
Q: Convalo released August 31, 2015 quarter over quarter growth rate of 145% and an annualized growth rate of 580%. Does this meet or exceed expectations? Would also appreciate your explanation of why the warrants expiry has been accelerated to Nov 17. Thanks
Q: Hi team, I recently sold MCD (in an RRSP) after the run up, and am looking to redeploy cash into a blue chip healthcare or pharma stock in the US. I'm looking for reliable dividends with capital appreciation, and planning to hold for three plus years. MRK and PFE are looking like good candidates, do you have any favourite blue chip healthcare stocks that you think would be a better fit?
Thanks, Alex
Thanks, Alex